in this issue
Chemical Week Magazine :: Newsbriefs
Russian pharma firm buys API supplier for $590 million
6:19 AM MDT | September 6, 2013
Pharmstandard (Moscow), Russiaâ€™s leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for $590 million. Russian businessman Alexander Shuster, a nonexecutive board member of Pharmstandard, currently owns 100% of Bever. Pharmstandard says it is buying Bever to secure a long-term supply of critical APIs for two flagship OTC brands of Pharmstandardâ€”Arbidol and Aphobazolumâ€”at lower cost, increase the profitability of the OTC business, improve flexibility, and manage APIs...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee